Repligen | RGEN - Себестоимость





Себестоимость Изменить Дата
Agilent USD 852M 19M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
Bio Techne USD 104.6M 6.16M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Bruker USD 528M 46.9M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 518M 55M 2025-12
General Electric Aerospace USD 8.15B 764M 2026-03
Henry Schein USD 2.44B 62M 2025-12
Illumina USD 400M 49M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Standard Biotools USD 12.41M 2.34M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 548.5M 47.4M 2026-03